Trenimon treatment in chronic hemoblastoses.
D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008206:Lymphatic Diseases / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D010954:Plasmacytoma / Q000188:drug therapy; D013920:Thrombocythemia, Essential / Q000188:drug therapy; D014228:Triaziquone / Q000009:adverse effects / Q000627:therapeutic use*; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
D014228:Triaziquone